15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

Combined immunotherapy could tackle advanced cancers

April 15, 2019 | Zen Vuong

City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.

City of Hope Physicians Announce New CAR T Breakthroughs at Annual ASH Meeting

December 14, 2017 | Letisia Marquez

New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.

Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma

December 11, 2017 | Katie Neith

Researchers led by Alex Herrera, M.D. have found that a combination of two immunotherapy drugs may be a more tolerable way for patients to fight the disease before a transplant.

Live from ASCO: Immunotherapy Is a Revolution in Medicine

June 5, 2017 | Cary A. Presant, M.D.

Here at ASCO 2017 in Chicago, we’ve been hearing about promising new clinical trials that have shown that immunotherapy can control some of the most resistant cancers.

Immunotherapy Gives Hodgkin Lymphoma Patient a Second Chance

May 26, 2017 | Samantha Bonar

Four years ago, Mark Paolera, now 39, was busy enjoying the typical active California lifestyle, including mountain biking, hiking and deep-sea fishing. After a battery of tests, Paolera was diagnosed with Stage 2 Hodgkin lymphoma in May of 2014.

Cancer insights: Exciting progress in kidney cancer research, treatment

March 10, 2016 | Sumanta Kumar Pal, M.D.

Sumanta Kumar Pal, co-director of City of Hope's Kidney Cancer Program, lists this year's top highlights in kidney cancer research and treatment.